Immune Cell Study Prompts Scientists to Rethink How to Tackle Infections

Article

Fresh insights into how immune cells are regulated could signal a new approach to tackling infections. Researchers have found that oxygen levels in the body can profoundly change the way immune cells behave. Scientists say the findings pave the way for new therapies that target the immune response to infection, with the potential to boost existing antibiotic treatments.

The research in mice found that bacterial infections have vastly different outcomes depending on levels of oxygen in the body when the infection takes hold.

If oxygen levels are low when infection strikes, the immune system launches a massive overreaction. A fatal illness ensues even though the bacteria have been cleared from the body. Exposure to low oxygen before infection, however, seems to protect the body from illness without compromising its ability to fight off bacteria. Researchers say the effects are caused by changes to the way the cells use energy, which reprograms their response.

If human cells are found to behave in the same way, tweaking their oxygen sensing mechanisms could hold the key to tackling infections, the team says. The findings are particularly relevant for people with chronic lung conditions, such as emphysema. They often have low levels of oxygen in their body and are more vulnerable to infections.

The study was carried out by scientists in the Medical Research Council Centre for Inflammation Research at the University of Edinburgh and is published in the journal Science Immunology.

Dr. Sarah Walmsley, of the MRC Centre for Inflammation Research at the University of Edinburgh, said, "We are excited by our observation that oxygen levels can regulate immune cell responses to infection. Targeting these pathways could have the potential to improve outcomes from infections where oxygen is limited."

Source: University of Edinburgh

Recent Videos
Lindsay K. Weir, MPH, CIC, Lead Infection Preventionist/Infection Preventionist III
•	Rebecca (Bartles) Crapanzano-Sigafoos, DrPH, MPH, CIC, FAPIC (corresponding author), executive director of APIC’s Center for Research, Practice, and Innovation, and lead author of the study.
Infection Control Today's Infection Intel: Staying Ahead With Company Updates and Product Innovations.
COVID-19 presentations at IDWeek in Las Angeles, California by Invivyd.   (Adobe Stock 333039083 by Production Perig)
Long COVID and Other Post-Viral Syndromes
Meet Jenny Hayes, MSN, RN, CIC, CAIP, CASSPT.
Infection Control Today Editorial Advisory Board: Fibi Attia, MD, MPH, CIC.
Andrea Thomas, PhD, DVM, MSc, BSc, director of epidemiology at BlueDot
mpox   (Adobe Stock 924156809 by Andreas Prott)
Meet Alexander Sundermann, DrPH, CIC, FAPIC.
Related Content